Myostatin

Shop Myostatin
Code ths10 applied at checkout
By The Health Stacks Research TeamUpdated September 20, 2026

Myostatin is a natural protein that every mammal's body makes. It is also called GDF8. Its main job is to put the brakes on muscle growth. When myostatin is very active, muscles stay smaller. When it is missing or blocked, muscles grow much bigger.

Scientists learned about this protein by studying animals. Some cattle, like the Limousin beef breed, carry natural changes (mutations) in the myostatin gene. Animals with these changes grow extra muscle, a trait called 'double muscling' [4]. This showed that turning down myostatin lets muscles grow. Doctors are interested because too much myostatin may play a role in diseases where muscles waste away, like cancer cachexia (severe muscle and weight loss in cancer patients) [1].

Exercise also changes myostatin levels as part of the body's muscle-to-brain signaling [6]. Most of what we know comes from animals and lab studies, not from proven medicines for people. No myostatin-blocking drug is approved yet. Blocking this protein might help people with muscle-wasting diseases someday, but it could also cause unknown problems since myostatin does other jobs in the body too. People should be careful with unproven products claiming to block myostatin.

Research-stageEarly-stage — evidence so far is mostly cell, animal, or preliminary human studies. Not an approved medicine. High confidence60–79 — backed by solid sources with good corroboration across multiple citations.

Benefits

What Myostatin Helps With

The benefits people report — backed by research.

Weight management (3)

Increases total body mass 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Enhancement of fat loss 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Decreases fat mass 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →

Musculoskeletal (2)

Muscle recovery 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Increase in lean mass 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →

More reported benefits (2)

Improves hindlimb grip strength 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →Liver health 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →

Free: The Peptide Stack Cheat-Sheet

You just read the research on Myostatin. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.

No spam. Unsubscribe anytime.

How People Use It

1 reported routine — each line links to the source it came from.

From published sources

Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.

SubQ

  • Injected via AAV1 (Adeno-Associated Virus) vector 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.

Safety

Known Side Effects

Adverse effects reported in the research and by community use.

  • Up to 40% of weight loss from GLP-1 drugs is due to muscle loss rather than fat lossModerate 80/100Rated 80/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ today.uconn.edu
  • Weight regain after discontinuing GLP-1 drugs is predominantly fat rather than muscleModerate 80/100Rated 80/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ today.uconn.edu
  • Muscle spasmsMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ nature.com
  • Mouth ulcerations/aphthous ulcersMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ nature.com
  • Urinary tract infectionMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ nature.com
  • HeadacheMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ nature.com

Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.

Get Myostatin

Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.

Shop Myostatin
Code ths10 applied at checkout

Evidence

Research Citations (5)

Every claim above traces back to a source you can check — here are 5 of them.

  • Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene.

    2003 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.

    2011 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Myostatin as a therapeutic target in Amyotrophic lateral sclerosis.

    2012 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting.

    2011 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Myostatin mutation associated with gross muscle hypertrophy in a child.

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source

News

Latest on Myostatin

Dated, sourced reporting that mentions Myostatin.

ClinicalMar 2, 2026

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial

The BELIEVE randomized phase 2 trial tested the ActRII-targeting muscle-preserving antibody bimagrumab alone and combined with semaglutide in adults with obesity over 72 weeks. At week 48, lean mass rose +1.0% to +1.1% with bimagrumab versus -4.7% to -6.9% with semaglutide. At week 72, the high-dose combination cut total body fat mass by -45.7% while largely preserving lean mass.

95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
MarketNov 17, 2023

Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle

STAT News (17 November 2023) reports on the biotech rush to build obesity drugs that protect muscle while cutting fat - an approach inspired by myostatin research and the double-muscled animals it produced. The piece lays out why lean-mass loss on GLP-1 medicines became the industry's next competitive frontier.

72/100Rated 72/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Research

Mighty mice head to space on an ISS muscle-and-bone mission

UConn Today (13 December 2019) covered the launch of myostatin-lacking mighty mice to the International Space Station, where researchers from Jackson Laboratory, UConn Health, and Connecticut Children studied how microgravity drains muscle and bone - and what a body that cannot sense myostatin does about it. The flight data fed later countermeasure work for astronauts and muscle-wasting patients alike.

70/100Rated 70/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Clinical

Apitegromab phase 3: myostatin-blocker improves movement in nonambulatory SMA

The SAPPHIRE trial (Lancet Neurology, September 2025) tested apitegromab - a myostatin-targeting antibody - atop existing SMA therapy in 240 nonambulatory children and adults. It met its primary endpoint with meaningful motor-function improvement versus placebo, the first phase 3 win for the myostatin-blocking approach in neuromuscular disease.

95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Research

A child with double muscle: the first human myostatin mutation

In the 24 June 2004 New England Journal of Medicine, Schuelke and colleagues reported a German boy born with gross muscle hypertrophy and unusually strong toddler-age movement, traced to an inherited myostatin loss. The case proved in people what mighty-mice experiments had shown: myostatin is the body's brake on muscle growth, and releasing it builds muscle.

95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →

See all Myostatin news →

Wondering how Myostatin pricing compares across suppliers? Our original market data shows the full picture.

See the State of the Peptide Market 2026 →

Related on The Health Stacks

Related peptides

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.